Primoris Wealth Advisors LLC cut its stake in shares of The Clorox Company (NYSE:CLX – Free Report) by 2.2% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,408 shares of the company’s stock after selling 100 shares during the period. Primoris Wealth Advisors LLC’s holdings in Clorox were worth $716,000 at the end of the most recent reporting period.
Several other large investors have also recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its stake in shares of Clorox by 0.8% in the fourth quarter. Vanguard Group Inc. now owns 15,507,152 shares of the company’s stock worth $2,518,517,000 after acquiring an additional 124,428 shares during the last quarter. Geode Capital Management LLC increased its position in Clorox by 2.3% in the 4th quarter. Geode Capital Management LLC now owns 3,098,302 shares of the company’s stock worth $501,925,000 after purchasing an additional 69,969 shares during the last quarter. Norges Bank purchased a new stake in shares of Clorox during the 4th quarter worth about $259,041,000. FMR LLC lifted its holdings in shares of Clorox by 75.4% during the 4th quarter. FMR LLC now owns 1,361,758 shares of the company’s stock valued at $221,163,000 after buying an additional 585,526 shares during the last quarter. Finally, Amundi grew its stake in shares of Clorox by 42.6% in the 4th quarter. Amundi now owns 1,032,283 shares of the company’s stock valued at $165,816,000 after buying an additional 308,234 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.
Wall Street Analyst Weigh In
Several equities analysts recently weighed in on CLX shares. Barclays cut their price objective on shares of Clorox from $139.00 to $134.00 and set an “underweight” rating on the stock in a research report on Friday. JPMorgan Chase & Co. reduced their price objective on shares of Clorox from $173.00 to $151.00 and set a “neutral” rating for the company in a research note on Friday. DA Davidson lowered their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 5th. StockNews.com downgraded Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Finally, Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $156.75.
Clorox Price Performance
NYSE:CLX opened at $141.35 on Friday. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The stock has a market cap of $17.41 billion, a P/E ratio of 38.62, a PEG ratio of 2.62 and a beta of 0.61. The company has a fifty day moving average price of $147.39 and a 200 day moving average price of $157.24. The Clorox Company has a one year low of $127.60 and a one year high of $171.37.
Clorox (NYSE:CLX – Get Free Report) last released its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the previous year, the firm earned $2.16 earnings per share. Analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current year.
Clorox Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be given a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a yield of 3.45%. Clorox’s dividend payout ratio (DPR) is currently 133.33%.
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
- Five stocks we like better than Clorox
- How is Compound Interest Calculated?
- Is McDonald’s Stock Serving a Value Meal to Investors?
- ETF Screener: Uses and Step-by-Step Guide
- Walgreens Comeback? Private Equity Circling for a Buyout
- What is the Australian Securities Exchange (ASX)
- Coca-Cola Stock Looks Refreshing After the Relief Rally
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.